COVID-19重症监护病房患者有创机械通气预测模型的推导与外部验证
本研究为回顾性队列研究,纳入巴西里约热内卢三家医院2020年3月至2021年8月期间346例COVID-19 ICU患者,旨在开发预测有创机械通气(IMV)的模型并与ROX指数比较。基于最低AIC且p值显著的模型包含SOFA评分(OR 1.46)、SpO2(OR 0.81)和呼吸努力信号(OR 9.13)。外部验证中,ROX指数AUC为0.683(准确性63%),AIC模型AUC为0.703(准确性69%),显著p值模型AUC为0.725(准确性79%),AUC间无显著差异。作者认为这些变量可能更有助于预测IMV需求。
要点
- 在346例COVID-19 ICU患者中,155例(44.8%)需要有创机械通气。
- 基于最低AIC且p值显著的预测模型包含SOFA评分(OR 1.46,95%CI 1.07-2.05)、SpO2(OR 0.81,95%CI 0.72-0.90)和呼吸努力信号(OR 9.13,95%CI 3.29-28.67)。
- 入院时ROX指数在IMV组低于非IMV组(7.3 [5.2-9.8] vs 9.6 [6.8-12.9],p<0.001)。
- 外部验证中,ROX指数AUC 0.683(准确性63%),AIC模型AUC 0.703(准确性69%),显著p值模型AUC 0.725(准确性79%),AUC间无显著差异。
- 作者认为SOFA评分、SpO2和呼吸努力信号可能比ROX指数更有助于预测COVID-19 ICU患者的有创机械通气需求。
适用人群与场景
- 年龄≥18岁、诊断为COVID-19的ICU患者。
- 排除标准:入住ICU最初24小时内接受有创机械通气、妊娠、临床决定仅予最小化终末期照护、主要结局数据缺失。
研究设计与关键结果
- 研究类型:回顾性队列研究,数据收集于2020年3月至2021年8月巴西里约热内卢三家医院。
- 共筛查656例患者,纳入346例;155例(44.8%)需要有创机械通气,191例(55.2%)不需要;男性207例(59.8%)。
- 根据最低AIC,入院时动脉高血压、糖尿病、肥胖、SOFA评分、心率、呼吸频率、SpO2、体温、呼吸努力信号和白细胞被确定为IMV预测因子。
- 根据最低AIC且p值显著,SOFA评分(OR 1.46,95%CI 1.07-2.05)、SpO2(OR 0.81,95%CI 0.72-0.90)和呼吸努力信号(OR 9.13,95%CI 3.29-28.67)是IMV的最佳预测因子。
- 入院时ROX指数在IMV组低于非IMV组(7.3 [5.2-9.8] vs 9.6 [6.8-12.9],p<0.001)。
- 外部验证人群中,ROX指数AUC为0.683(准确性63%),AIC模型AUC为0.703(准确性69%),最低AIC且p值显著模型AUC为0.725(准确性79%)。
- 外部验证中,各模型AUC间无显著差异,但使用SOFA评分、SpO2和呼吸努力信号的准确性高于ROX指数。
证据类型、等级与局限
- 证据类型:回顾性队列研究,外部验证使用国际数据库。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在COVID-19 ICU患者中,SOFA评分、SpO2和呼吸努力信号可能比ROX指数更有助于预测有创机械通气需求。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to develop prognostic models for predicting the need for invasive mechanical ventilation (IMV) in intensive care unit (ICU) patients with COVID-19 and compare their performance with the Respiratory rate-OXygenation (ROX) index.
METHODS: A retrospective cohort study was conducted using data collected between March 2020 and August 2021 at three hospitals in Rio de Janeiro, Brazil. ICU patients aged 18 years and older with a diagnosis of COVID-19 were screened. The exclusion criteria were patients who received IMV within the first 24 h of ICU admission, pregnancy, clinical decision for minimal end-of-life care and missing primary outcome data. Clinical and laboratory variables were collected. Multiple logistic regression analysis was performed to select predictor variables. Models were based on the lowest Akaike Information Criteria (AIC) and lowest AIC with significant p values. Assessment of predictive performance was done for discrimination and calibration. Areas under the curves (AUC)s were compared using DeLong's algorithm. Models were validated externally using an international database.
RESULTS: Of 656 patients screened, 346 patients were included; 155 required IMV (44.8%), 191 did not (55.2%), and 207 patients were male (59.8%). According to the lowest AIC, arterial hypertension, diabetes mellitus, obesity, Sequential Organ Failure Assessment (SOFA) score, heart rate, respiratory rate, peripheral oxygen saturation (SpO2), temperature, respiratory effort signals, and leukocytes were identified as predictors of IMV at hospital admission. According to AIC with significant p values, SOFA score, SpO2, and respiratory effort signals were the best predictors of IMV; odds ratios (95% confidence interval): 1.46 (1.07-2.05), 0.81 (0.72-0.90), 9.13 (3.29-28.67), respectively. The ROX index at admission was lower in the IMV group than in the non-IMV group (7.3 [5.2-9.8] versus 9.6 [6.8-12.9], p < 0.001, respectively). In the external validation population, the area under the curve (AUC) of the ROX index was 0.683 (accuracy 63%), the AIC model showed an AUC of 0.703 (accuracy 69%), and the lowest AIC model with significant p values had an AUC of 0.725 (accuracy 79%).
CONCLUSIONS: In the development population of ICU patients with COVID-19, SOFA score, SpO2, and respiratory effort signals predicted the need for IMV better than the ROX index. In the external validation population, although the AUCs did not differ significantly, the accuracy was higher when using SOFA score, SpO2, and respiratory effort signals compared to the ROX index. This suggests that these variables may be more useful in predicting the need for IMV in ICU patients with COVID-19.
GOV IDENTIFIER: NCT05663528.
参考来源
- Maia G, Martins CM, Marques V, et al. Derivation and external validation of predictive models for invasive mechanical ventilation in intensive care unit patients with COVID-19. Ann Intensive Care. 2024. PMID: 39167241. doi:10.1186/s13613-024-01357-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。